Recent Headlines
Alera Bio Announces Appointment of Board of Directors
Alera Bio, a Chicago-based biotech developing therapies for rare neuroendocrine and neurological disorders, announced its inaugural Board of Directors. The board includes leaders in biopharma, clinical practice, and finance, such as Stephen Hill, Mark Prygocki, Renny Griffith, and Cassius Coleman. Their combined expertise will guide Alera Bio as it advances AB-101 for MCT-8 deficiency, an FDA-designated Rare Pediatric Disease therapy. - November 11, 2025 - Alera Bio
MVT Reports Breakthrough Preclinical Results for MVT‑101 in DVT Model
Microvascular Therapeutics, Inc. (MVT) today announced the publication of compelling preclinical data demonstrating that its proprietary phase‑shift microbubble platform, MVT‑101 (Solv), significantly enhances sonothrombolysis in a clinically relevant porcine model of deep vein thrombosis (DVT). The study appears in the peer‑reviewed journal Nanotheranostics (Vol. 9, Issue 3, 2025). - November 04, 2025 - Microvascular Therapeutics, Inc.
True Marker Pharmaceuticals Hits Another Trust & Credibility Milestone
True Marker Pharmaceuticals, Inc., a licensed pharmaceutical wholesaler and repackager based in Phoenix, has earned BBB Accreditation, recognizing its commitment to ethical business practices, transparency, and regulatory compliance. The achievement aligns with True Marker’s expanding U.S. distribution network and reinforces its reputation as a trusted, DSCSA-compliant partner to independent pharmacies and healthcare providers nationwide. - October 28, 2025 - True Marker Pharmaceuticals, Inc.
Fleming Events Launches “Digital Quality in Clinical Trials” Training to Address New ICH E6 (R3) GCP Expectations
Fleming Events, a global provider of professional training and industry knowledge programs, has announced its upcoming masterclass Digital Quality in Clinical Trials, scheduled for 22–23 April 2026 in Vienna, Austria. The training comes at a critical time as regulators worldwide increase... - October 28, 2025 - Fleming Events
Finetech Updates All Plastic Ampoule Filling Machines; Now Introduces 1 New Series of Machines
Finetech has launched a new line of plastic ampoule filling machines designed to meet small-dose filling needs, suitable for filling solutions for test drugs, cosmetics, health products and food. - October 27, 2025 - Finetech
New Report Uncovers What Sponsors Really Think About Preclinical Services and CROs
Life Science Strategy Group’s Preclinical Services Landscape and CRO Benchmarking Assessment Delivers Data-Driven Insights on Budgets, Outsourcing, Vendor Preferences, and Industry Shifts - October 16, 2025 - Life Science Strategy Group, LLC
IVC Hosts Charity Golf Tournament, Donates $100,000 to Support Local Communities
IVC proudly hosted its annual Charity Golf Tournament on October 8 at The Cliffs at Mountain Park Golf Club, bringing together employees, partners, and community members for a day of camaraderie, giving, and impact. As part of the event, IVC donated $50,000 each to March of Dimes in Anderson, SC,... - October 11, 2025 - International Vitamin Corporation
Radial Celebrates the Grand Opening of Its Second South Carolina Clinic in Downtown Conway
More than 60 community members and business leaders join for ribbon cutting ceremony with the Conway Chamber of Commerce. - October 11, 2025 - Radial
Alera Bio Announces Appointment of Executive Leadership Team
Alera Bio announced its executive team: Philip Vorhies (CEO), Peter Thomson (CFO), Eric Floyd, PhD (CRO), and Caitlin Murray (GC), supported by expert consultants. Founder Frank Jaeger noted their strength in biotech, finance, regulatory, and legal, positioning Alera to advance AB-101 for MCT-8 deficiency, a rare neurological disorder with FDA Rare Pediatric Disease designation. - September 26, 2025 - Alera Bio
Madison Avenue Group Announces Christine Nguyen as Official Partner
In 2021, Madison Avenue Group was founded with a clear mission: to help brands scale and grow through the power of influencer marketing. What began as a solo venture by founder Hollie Nguyen has now grown into a partnership built on strength, resilience, and vision. - September 26, 2025 - Madison Ave Group
Natural Cure Labs’ Level Off Gains Traction as Americans Seek Metabolic Health
Natural Cure Labs has updated its Level Off glucose support supplement to include loquat leaf extract, expanding the formula’s evidence base for healthier post-meal glucose balance. With only 12% of U.S. adults metabolically healthy, the enhancement underscores rising demand for natural solutions. - September 24, 2025 - Natural Cure Labs
French Biotech 4Dcell Selected to Showcase Next-Gen Cardiac Drug Testing Platform at EIC Corporate Day
French Startup 4Dcell Wins Spot to Show Next-Gen Cardiac Drug Testing Platform at EIC - September 24, 2025 - 4Dcell
YOLO Immune Awarded National Science Foundation SBIR Grant to Advance Novel Immunotherapy for the Treatment of Autoimmune Diseases
YOLO Immune, Inc., a venture-backed biotech company developing precision immunotherapies for the treatment of serious human diseases, today announced it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF). The NSF SBIR program is... - September 19, 2025 - YOLO Immune Inc
Alera Bio Launches Lead Rare Disease Program with Exclusive Rights to MCT-8 Deficiency Therapy
Alera Bio secures exclusive license to advance AB-101, a first-in-class program for MCT-8 deficiency, with FDA Rare Pediatric Disease designation already in place. - September 18, 2025 - Alera Bio
Dr. David Pincus of Pincus Plastic Surgery Named #1 Plastic Surgeon in New York and Florida by Hippo Medical
Board-Certified Plastic Surgeon Dr. David Pincus, founder of Pincus Plastic Surgery, has been honored with the America’s Top Plastic Surgeon Award by Hippo Medical, recognizing him as the #1 plastic surgeon in both New York and Florida for his excellence in patient safety, surgical artistry, and natural aesthetic results. - September 17, 2025 - Pincus Plastic Surgery
Longevity World Cup Launches: A Global Sport Where Age is the Advantage
The Longevity World Cup, launching September 16, 2025, is the first global competition where athletes win by reversing their biological age. Rankings are based on verified tests using the PhenoAge clock, with categories by gender and generation. Prize money, funded in Bitcoin, goes to the top athletes. - September 16, 2025 - Longevity World Cup
From Customer to CEO: Kaitlyn Talamante Acquires LadyBoss, the Women’s Health Brand Empowering Hundreds of Thousands Since 2014
LadyBoss, the women’s health and lifestyle brand founded in 2014 by Kaelin and Brandon Poulin, later sold to Russell Brunson in 2022, announces its new owner, Kaitlyn Talamante. A former LadyBoss customer turned CEO, Talamante’s journey from personal transformation to leading the brand represents a full-circle story of empowerment, growth, and vision for the future. - September 05, 2025 - LadyBoss
CABRI Fellowship Program Opens for Undergraduate Research Applicants
The Cayman Biomedical Research Institute (CABRI) has announced that applications are now open for their undergraduate research fellowships. Applications may be submitted on the CABRI website from August 11, 2025 through September 29, 2025. - August 15, 2025 - Cayman Chemical Company
New Book “Life Lessons From the Overhead Bin: A Flight Attendant’s Advice on How to Be Fit, Fearless and Fulfilled After 50” Uplifts and Inspires Women to Soar in Midlife
In her debut book, author Helen Fritsch weaves observations and stories from her 40-year career in the sky with her unique inspirational advice and practical tips. - August 14, 2025 - Helen Fritsch
YOLO Immune Inc. Emerges from Stealth Mode
YOLO Immune Inc. has emerged from stealth mode to unveil its human-centric drug discovery process and to announce the promotion of its founding research team. YOLO Immune is a venture-backed biotech company developing precision immunotherapies for the treatment of serious human diseases. The... - July 31, 2025 - YOLO Immune Inc
ERBESSD INSTRUMENTS Continues Global Expansion
ERBESSD INSTRUMENTS a global leader in dynamic balancing, vibration analysis, machinery health, and process health instrumentation and optimization announces expansion to Latin America. - July 25, 2025 - ERBESSD INSTRUMENTS
GENINVO Celebrates 8 Years of Innovation and Growth in the Life Sciences Industry
GENINVO, a leading provider of transformative digital solutions for the life sciences sector, proudly celebrates its 8th anniversary—a journey marked by innovation, collaboration, and impactful contributions across global healthcare and pharmaceutical domains. From a vision sparked eight... - July 22, 2025 - GenInvo, Inc.
Aphora Health Acquires CareNexis to Accelerate Innovation in Specialty Pharmacy Benefits and AI-Driven Insights for Self-Insured Employers
Aphora Health, a leading provider of cost containment solutions and advanced pharmacy benefit strategies for self-insured employers, announces the acquisition of CareNexis, a digital health company known for its proprietary consumer health intelligence and engagement platform. This acquisition... - July 10, 2025 - Aphora Health
Alera Bio Launches to Advance Breakthrough Therapies for Rare Neurological Disorders
Chicago-based Alera Bio has launched with a mission to develop treatments for ultra-rare and neglected neurological disorders, especially in children. Combining scientific innovation with patient urgency, the company will pursue both novel and repurposed therapies via orphan drug and 505(b)(2) pathways. With a lean, capital-efficient model, Alera Bio aims to rapidly advance therapies that address critical gaps in care. - July 03, 2025 - Alera Bio
Fantastic Nutrition Launches Creatine Fantastic, a Science-Based Supplement Featuring Creatine and myHMB® for Enhanced Muscle Strength and Recovery
Research shows that combining creatine with myHMB can increase lean muscle mass up to 30% more than creatine alone (Wilson et al., 2014, Journal of the International Society of Sports Nutrition). This blend not only helps build muscle and recover faster, but also reduces muscle degradation, enhances athletic performance, and supports cognitive function—a total performance formula for both body and mind. - June 15, 2025 - Fantastic Nutrition
H3Tech Welcomes Ruiban Coutinho as AI Healthtech Consultant
H3Tech, a healthcare technology and consulting firm, has appointed Ruiban Coutinho as AI Healthtech Consultant. With 14 years of experience in data analytics and business intelligence, Coutinho will leverage his expertise in AI, SAP BW/HANA, and Power BI to enhance H3Tech’s AI-driven healthcare solutions. - June 06, 2025 - H3Tech
Good Mana Knows the Secret to Powerful Health Benefits: ʻŌlena Gold Turmeric - A Premium Organic Supplement Grown in Nutrient-Dense Hawaiian Soil
Good Mana, based in Waimanalo, Hawai'i, is raising the industry standard for potency, purity and traceability of turmeric supplements with its premium ʻŌlena Gold Turmeric brand. - May 24, 2025 - Good Mana
New QualiFam Autism Protocol Now Available in U.S. Treats Root Biological Causes Behind Symptoms
Developed by physician-scientist Dr. Ken Alibek, the QualiFam Protocol delivers results in as little as three months by targeting immune and infection-linked triggers. - May 16, 2025 - QualiFam
Microvascular Therapeutics: Positive Clinical Trial Results with Lead Candidate, CardiSon (MVT-100)
Microvascular Therapeutics, Inc. (MVT), a biotechnology company, announced that it has completed data analysis of its Phase II trial of its new ultrasound contrast agent, MVT-100, CardiSon, in echocardiography. In this study, 16 subjects received either the predicate agent Perflutren, or CardiSon,... - May 15, 2025 - Microvascular Therapeutics, Inc.
Truvy® and Sweet Minerals Partner to Expand Global Health & Beauty Opportunities via Bytru.com
Truvy® has integrated the product and multi-level marketing (MLM) operations of Sweet Minerals into its business at Bytru, making Sweet Minerals’ celebrated beauty products available to a broader global audience. - May 12, 2025 - Truvy
Vetirus Pharmaceuticals Acquires Enso Discoveries to Expand Regenerative Medicine Portfolio
Vetirus Pharmaceuticals, a multinational company headquartered in Naples, Florida, and London, UK, announced its acquisition of Enso Discoveries, LLC, a Manhattan, Kansas-based biotech company specializing in regenerative medicine. The acquisition was revealed at the 10th annual Animal Health, Nutrition, and Technology Innovation Europe. - April 30, 2025 - Vetirus Animal Health
Mirror Biologics Announces Publication of Clinical Results Showing Potential for Allo-Priming to Provide Broad Protection to Elderly from Respiratory Viral Infection
A new approach for pandemic preparedness and protection of the elderly from any type of respiratory viral infection. Five injections over two weeks provides possible universal viral protection without need for booster shots. - April 28, 2025 - Mirror Biologics, Inc.
International Vitamin Corporation (IVC) Appoints Nora Dowell as Senior Vice President of Quality, Regulatory, and R&D
IVC is pleased to announce the appointment of Nora Dowell as Senior Vice President of Quality, Regulatory, and R&D, marking a significant step forward in the company’s ongoing commitment to delivering high-quality, compliant, and innovative health and wellness products. Nora brings more than 30 years of experience in regulatory compliance and quality management systems, with deep expertise in cGMP, QMS, FSMA/FSVP, training, auditing, labeling, and supplier qualifications. - April 26, 2025 - International Vitamin Corporation
Parvus Announces Achievement of First Milestone from its Collaboration Agreement with AbbVie to Develop IBD Therapies Based on the Parvus Nanomedicine Platform Technology
IND-enabling nonclinical and manufacturing activities executed by Parvus met prospective criteria resulting in the first milestone payment from AbbVie. - April 21, 2025 - Parvus Therapeutics U.S., Inc.
GENINVO Announces Its Latest Innovation – Confidential Information Scanner (CIS) Tool
GENINVO, a leading provider of life science technology solutions, is proud to announce the launch of its latest innovation – the Confidential Information Scanner (CIS) Tool. This tool is designed to help organizations identify publicly available company confidential information (CCI) across... - April 12, 2025 - GenInvo, Inc.
Minus K Congratulates to the following winners of their 2024/2025 Educational Giveaway
Celebrating its’ tenth year of their U.S. Educational Giveaway, Minus K Technology has to-date granted over $100,000 of its superior performing patented Negative-Stiffness low-frequency passive mechanical vibration isolators to colleges and universities in the USA. - April 03, 2025 - Minus K Technology Inc.
Apeximmune Therapeutics Announces Successful Close of Series A Fundraising Round to Advance Next-Generation Immunotherapies
Apeximmune Therapeutics, a biotechnology company pioneering next-generation immunotherapies, today announced the successful close of its Series A financing round, raising $21.3 million, exceeding its original goal of $20 million. The funding was led by PharmaEssentia Corporation, with participation... - April 01, 2025 - Apeximmune Therapeutics
Huntington Study Group Announces Executive Director of Clinical Operations
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to introduce Carolyn Schultz-Walter as the Executive Director of Clinical Operations. With over 25 years of global clinical operations experience spanning both sponsor and clinical research... - March 31, 2025 - Huntington Study Group
Thar Process and Clean Heat Technologies Integrate CO2 Heat Pump Technology to Make Supercritical CO2 Technology a Low Cost Solution
Thar Process and Clean Heat Technologies have successfully engineered, integrated and installed electric heat pumps using CO2 - R744 - as the upcycled, natural refrigerant. The technology partnership means that Thar Process' clients can benefit from lower operating costs. Thar is known for it's innovative use of CO2 for extracting flavors, fragrances, medicinal and therapeutic compounds both in it's GMP certified facility in Pittsburgh and at client sites globally. - March 24, 2025 - Thar Process
SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug for the Treatment of Cancer at the American Association for Cancer Research (AACR) Annual Meeting 2025
SignaBlok will present positive preclinical data on targeting innate inflammation for the treatment of hard-to-treat cancers. In combination with standard-of-care chemotherapy, SignaBlok's new mechanism-based inhibitor of TREM-1, an inflammation amplifier, prevents cancer recurrence, improves complete response rate and survival in experimental pancreatic cancer. In combination with anti-PD-L1 treatment, it overcomes pancreatic cancer resistance to immunotherapy. - March 21, 2025 - SignaBlok, Inc.
SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug at the Respiratory Innovation Summit and American Thoracic Society International Conference 2025
SignaBlok will present positive preclinical data on targeting innate inflammation for the treatment of sepsis and pulmonary diseases. In experimental sepsis, SignaBlok's new mechanism-based inhibitor of TREM-1, an inflammation amplifier, protects from death with the level of protection not declining at delayed treatment times. In pulmonary inflammation and fibrosis in rats and mice, it reduces neutrophil infiltration in the lungs and reverses fibrosis. - March 21, 2025 - SignaBlok, Inc.
West Bengal Chemical Industries Limited Introduces Liposomal Skincare Technology
Liposomal technology, an advance technology, involves encapsulating active ingredients within lipid bilayers. - March 11, 2025 - West Bengal Chemical Industries Limited
HistAI Unveils Groundbreaking SPIDER Initiative at HIMSS Conference
At the HIMSS Conference, HistAI announced the SPIDER Initiative, an open-source project set to become the largest supervised medical imaging dataset. The initiative will compile more than 50 millions of fully annotated images from 20 organs and 400 morphologies, advancing AI-driven diagnostics, precision medicine, and drug development. The first release includes more than 4 millions of images from 6K Whole Slide Images (WSIs) across Skin, Colorectal, and Thorax. Available starting today. - March 06, 2025 - HistAI
matrihealth GmbH Qualifies Soluble Elastin Hydrolysate matripure® for Use in Cosmetics
matrihealth GmbH has qualified matripure® elastin for use in cosmetics, providing manufacturers with a high-quality raw material made in Germany. - March 06, 2025 - matrihealth GmbH
Regenexx® Corporate Program's Dr. Mark Testa Wins the YOU Powered Symposium 2025 Most Influential Clinician in Insurance Award
The YOU Powered Symposium is the leading annual event for "bold benefits trailblazers." It brings together hundreds of benefit professionals, solution providers, clinicians, and employers to combine diverse expertise in an effort to reform the US healthcare system on behalf of every patient. - March 04, 2025 - Regenexx Corporate Program
Trump-Era Administration Drug Development & Outsourcing Impact Report
How Tariffs and RFK Jr.’s HHS Appointment May Shift Drug Development & Outsourcing - February 27, 2025 - Life Science Strategy Group, LLC
Two Peoria Residents Win $20,000 in National Transformation Contest
Wayne Galpin and Kaitlyn Willis of FXB Peoria have won the 2024 Farrell’s National Challenge, each earning $10,000 for their remarkable yearlong fitness transformations. Farrell’s eXtreme Bodyshaping (FXB) combines kickboxing, strength training, nutrition coaching, and accountability to help members achieve lasting health results. Their dedication not only transformed their lives but also inspired their community. - February 19, 2025 - Farrell's Extreme Body Shaping
Legacy Pharma Inc. SEZC Announces the Acquisition of InterMune, Inc. and the U.S. Rights to Esbriet® from Genentech a Member of the Roche Group
Legacy Pharma Inc. SEZC (“Legacy Pharma” or the “Company”), a specialty pharmaceutical company, announced the completion of the acquisition of InterMune, Inc. (“InterMune”) and the intellectual property rights to Esbriet® (pirfenidone) in the United States... - February 06, 2025 - Legacy Pharma Inc. SEZC
Purple Diamond Hosting Exclusive Webinar on Pharmaceutical Packaging Validation and Product Integrity
Purple Diamond, a leading ISO-accredited package testing lab, will host a free webinar on February 4, at 2 pm EST. "Protecting Pharma Integrity: The Science of Packaging Validation" will provide insights into testing methodologies and tools critical for ensuring pharmaceutical packaging safety and compliance. - January 16, 2025 - Purple Diamond Testing
Regenexx Announces Dr. Philippe Hernigou as New Medical Director of Clinical Research
Regenexx®, a leader in regenerative medicine and advanced orthobiologics, is proud to announce that Dr. Philippe Hernigou, a globally recognized expert in autologous cell therapy and musculoskeletal regeneration, has joined the company as its new Medical Director of Clinical Research. Dr. - December 11, 2024 - Regenexx Corporate Program